학술논문
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
Document Type
Article
Author
Younes, Anas; Santoro, Armando; Shipp, Margaret; Zinzani, Pier Luigi; Timmerman, John M; Ansell, Stephen; Armand, Philippe; Fanale, Michelle; Ratanatharathorn, Voravit; Kuruvilla, John; Cohen, Jonathon B; Collins, Graham; Savage, Kerry J; Trneny, Marek; Kato, Kazunobu; Farsaci, Benedetto; Parker, Susan M; Rodig, Scott; Roemer, Margaretha G M; Ligon, Azra H; Engert, Andreas
Source
In The Lancet Oncology September 2016 17(9):1283-1294
Subject
Language
ISSN
1470-2045